PCC > Academics > Areas of Study > Health Professions > EMS > Syllabi > EMS 233 5.11

COURSE SYLLABUS

EMS 233 EMT-P Medical Emergencies

Return to the EMS 233 main page

5.11 UNIT TERMINAL OBJECTIVE

5-11 At the completion of this unit, the paramedic student will be able to integrate pathophysiological principles and assessment findings to formulate a field impression and implement a management plan for the patient with infectious and communicable diseases.

At the completion of this unit, the paramedic student will be able to:

5-11.1 Review the specific anatomy and physiology pertinent to infectious and communicable diseases. (C-1)

5-11.2 Define specific terminology identified with infectious/ communicable diseases. (C-1)

5-11.3 Discuss public health principles relevant to infectious/ communicable disease. (C-1)

5-11.4 Identify public health agencies involved in the prevention and management of disease outbreaks. (C-1)

5-11.5 List and describe the steps of an infectious process. (C-1)

5-11.6 Discuss the risks associated with infection. (C-1)

5-11.7 List and describe the stages of infectious diseases. (C-1)

5-11.8 List and describe infectious agents, including bacteria, viruses, fungi, protozoans, and helminths (worms). (C-1)

5-11.9 Describe host defense mechanisms against infection. (C-1)

5-11.10 Describe characteristics of the immune system, including the categories of white blood cells, the reticuloendothelial system (RES), and the complement system. (C-1)

5-11.11 Describe the processes of the immune system defenses, to include humoral and cell-mediated immunity. (C-1)

5-11.12 In specific diseases, identify and discuss the issues of personal isolation. (C-1)

5-11.13 Describe and discuss the rationale for the various types of PPE. (C-1)

5-11.14 Discuss what constitutes a significant exposure to an infectious agent. (C-1)

5-11.15 Describe the assessment of a patient suspected of, or identified as having, an infectious/ communicable disease. (C-1)

5-11.16 Discuss the proper disposal of contaminated supplies (sharps, gauze sponges, tourniquets, etc.). (C-1)

5-11.17 Discuss disinfection of patient care equipment, and areas in which care of the patient occurred. (C-1)

5-11.18 Discuss the following relative to HIV - causative agent, body systems affected and potential secondary complications, modes of transmission, the seroconversion rate after direct significant exposure, susceptibility and resistance, signs and symptoms, specific patient management and personal protective measures, and immunization. (C-1)

5-11.19 Discuss Hepatitis A (infectious hepatitis), including the causative agent, body systems affected and potential secondary complications, routes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.20 Discuss Hepatitis B (serum hepatitis), including the causative agent, the organ affected and potential secondary complications, routes of transmission, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.21 Discuss the susceptibility and resistance to Hepatits B. (C-1)

5-11.22 Discuss Hepatitis C, including the causative agent, the organ affected, routes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization and control measures. (C-1)

5-11.23 Discuss Hepatitis D (Hepatitis delta virus), including the causative agent, the organ affected, routes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization and control measures. (C-1)

5-11.24 Discuss Hepatitis E, including the causative agent, the organ affected, routes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization and control measures. (C-1)

5-11.25 Discuss tuberculosis, including the causative agent, body systems affected and secondary complications, routes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization and control measures. (C-1)

5-11.26 Discuss meningococcal meningitis (spinal meningitis), including causative organisms, tissues affected, modes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization and control measures. (C-1)

5-11.27 Discuss other infectious agents known to cause meningitis including streptococcus pneumonia, hemophilus influenza type b, and other varieties of viruses. (C-1)

5-11.28 Discuss pneumonia, including causative organisms, body systems affected, routes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.29 Discuss tetanus, including the causative organism, the body system affected, modes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.30 Discuss rabies and hantavirus as they apply to regional environmental exposures, including the causative organisms, the body systems affected, routes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization and control measures. (C-1)

5-11.31 Identify pediatric viral diseases. (C-3)

5-11.32 Discuss chickenpox, including the causative organism, the body system affected, mode of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization and control measures. (C-1)

5-11.33 Discuss mumps, including the causative organism, the body organs and systems affected, mode of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.34 Discuss rubella (German measles), including the causative agent, the body tissues and systems affected, modes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.35 Discuss measles (rubeola, hard measles), including the causative organism, the body tissues, organs, and systems affected, mode of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.36 Discuss the importance of immunization, and those diseases, especially in the pediatric population, which warrant widespread immunization (MMR). (C-1)

5-11.37 Discuss pertussis (whooping cough), including the causative organism, the body organs affected, mode of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.38 Discuss influenza, including causative organisms, the body system affected, mode of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.39 Discuss mononucleosis, including the causative organisms, the body regions, organs, and systems affected, modes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.40 Discuss herpes simplex type 1, including the causative organism, the body regions and system affected, modes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.41 Discuss the characteristics of, and organisms associated with, febrile and afebrile respiratory disease, to include bronchiolitis, bronchitis, laryngitis, croup, epiglottitis, and the common cold. (C-1)

5-11.42 Discuss syphilis, including the causative organism, the body regions, organs, and systems affected, modes of transmission, susceptibility and resistance, stages of signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.43 Discuss gonorrhea, including the causative organism, the body organs and associated structures affected, mode of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.44 Discuss chlamydia, including the causative organism, the body regions, organs, and systems affected, modes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.45 Discuss herpes simplex 2 (genital herpes), including the causative organism, the body regions, tissues, and structures affected, mode of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.46 Discuss scabies, including the etiologic agent, the body organs affected, modes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.47 Discuss lice, including the infesting agents, the body regions affected, modes of transmission and host factors, susceptibility and resistance, signs and symptoms, patient management and protective measures, and prevention. (C-1)

5-11.48 Describe lyme disease, including the causative organism, the body organs and systems affected, mode of transmission, susceptibility and resistance, phases of signs and symptoms, patient management and control measures, and immunization. (C-1)

5-11.49 Discuss gastroenteritis, including the causative organisms, the body system affected, modes of transmission, susceptibility and resistance, signs and symptoms, patient management and protective measures, and immunization. (C-1)

5-11.50 Discuss the local protocol for reporting and documenting an infectious/ communicable disease exposure. (C-1)

5-11.51 Articulate the pathophysiological principles of an infectious process given a case study of a patient with an infectious/ communicable disease. (C-3)

5-11.52 Articulate the field assessment and management, to include safety considerations, of a patient presenting with signs and symptoms suggestive of an infectious/ communicable disease. (C-3)

At the completion of this unit, the paramedic student will be able to:

5-11.53 Advocate compliance with standards and guidelines by role modeling adherence to universal/ standard precautions and BSI. (A-1)

5-11.54 Value the importance of immunization, especially in children and populations at risk. (A-1)

5-11.55 Value the safe management of a patient with an infectious/ communicable disease. (A-2)

5-11.56 Advocate respect for the feelings of patients, family, and others at the scene of an infectious/ communicable disease. (A-2)

5-11.57 Advocate empathy for a patient with an infectious/ communicable disease. (A-2)

5-11.58 Value the importance of infectious/ communicable disease control. (A-2)

5-11.59 Consistently demonstrate the use of body substance isolation. (A-2)

At the completion of this unit, the paramedic student will be able to:

5-11.60 Demonstrate the ability to comply with body substance isolation guidelines. (P-2)

5-11.61 Perform an assessment of a patient with an infectious/ communicable disease. (P-2)

5-11.62 Effectively and safely manage a patient with an infectious/ communicable disease, including airway and ventilation care, support of circulation, pharmacological intervention, transport considerations, psychological support/ communication strategies, and other considerations as mandated by local protocol. (P-2)

5.12 UNIT TERMINAL OBJECTIVE

5-12 At the end of this unit, the paramedic student will be able to describe and demonstrate safe, empathetic competence in caring for patients with behavioral emergencies.

At the completion of this unit, the paramedic student will be able to:

5-12.1 Define behavior and distinguish between normal and abnormal behavior. (C-1)

5-12.2 Define behavioral emergency. (C-1)

5-12.3 Discuss the prevalence of behavior and psychiatric disorders. (C-1)

5-12.4 Discuss the factors that may alter the behavior or emotional status of an ill or injured individual. (C-1)

5-12.5 Describe the medical legal considerations for management of emotionally disturbed patients. (C-1)

5-12.6 Discuss the pathophysiology of behavioral and psychiatric disorders. (C-1)

5-12.7 Describe the overt behaviors associated with behavioral and psychiatric disorders. (C-1)

5-12.8 Define the following terms: (C-1)

1. Affect
2. Anger
3. Anxiety
4. Confusion
5. Depression
6. Fear
7. Mental status
8. Open-ended question
9. Posture

5-12.9 Describe the verbal techniques useful in managing the emotionally disturbed patient. (C-1)

5-12.10 List the reasons for taking appropriate measures to ensure the safety of the patient, paramedic and others. (C-1)

5-12.11 Describe the circumstances when relatives, bystanders and others should be removed from the scene. (C-1)

5-12.12 Describe the techniques that facilitate the systematic gathering of information from the disturbed patient. (C-1)

5-12.13 List situations in which the EMT-P is expected to transport a patient forcibly and against his will. (C-1)

5-12.14 Identify techniques for physical assessment in a patient with behavioral problems. (C-1)

5-12.15 Describe methods of restraint that may be necessary in managing the emotionally disturbed patient. (C-1)

5-12.16 List the risk factors for suicide. (C-1)

5-12.17 List the behaviors that may be seen indicating that patient may be at risk for suicide. (C-1)

5-12.18 Integrate the pathophysiological principles with the assessment of the patient with behavioral and psychiatric disorders. (C-3)

5-12.19 Differentiate between the various behavioral and psychiatric disorders based on the assessment and history. (C-3)

5-12.20 Formulate a field impression based on the assessment findings. (C-3)

5-12.21 Develop a patient management plan based on the field impressions. (C-3)

At the completion of this unit, the paramedic student will be able to:

Advocate for empathetic and respectful treatment for individuals experiencing behavioral emergencies. (A-3)

At the completion of this unit, the paramedic student will be able to:

5-12.23 Demonstrate safe techniques for managing and restraining a violent patient. (P-1)